Methods
-11, EYE
The trial was conducted at 5 University Eye Clinics in Rome, Barcelona, Leuven, Thessaloniki, and Milan between winter 2019 and summer 2021. The study was designed following the tenets of the Declaration of Helsinki, and the protocol was submitted and approved by each University Ethics Committee. The trial was funded by Omikron Italia®a srl and registered (EudraCT 2018–002187-11, clinicaltrials.gov).